Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tawara

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|July 6, 2000
Orally active cephalosporins. Part 2: synthesis, structure-activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chainH Yamamoto, T Terasawa, A Nakamura, et al.
Chemotherapy|May 16, 2002
In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important moldsT Nakai, J Uno, K Otomo, et al.
The Journal of Antibiotics|December 1, 1988
In vivo antibacterial activity of FK482, a new orally active cephalosporinY Mine, Y Yokota, Y Wakai, et al.
The Journal of Antibiotics|October 8, 1999
In vitro antibacterial activity of FK041, a new orally active cephalosporinY Watanabe, K Hatano, Y Matsumoto, et al.
The Journal of Antibiotics|January 1, 1993
Animal pharmacokinetics of FK037, a novel parenteral broad-spectrum cephalosporinH Sakamoto, K Hatano, Y Higashi, et al.
Bioorganic & Medicinal Chemistry|March 16, 2001
Orally active cephalosporins. Part 3: synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporinsH Yamamoto, T Terasawa, A Nakamura, et al.
The Journal of Antibiotics|December 1, 1988
In vitro antibacterial activity of FK482, a new orally active cephalosporinY Mine, T Kamimura, Y Watanabe, et al.
Bioorganic & Medicinal Chemistry|September 1, 2000
Orally active cephalosporins: synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporinsH Yamamoto, T Terasawa, A Ohki, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosisF Ikeda, Y Wakai, S Matsumoto, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosisS Matsumoto, Y Wakai, T Nakai, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|July 6, 2000
Orally active cephalosporins. Part 2: synthesis, structure-activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chainH Yamamoto, T Terasawa, A Nakamura, et al.
Chemotherapy|May 16, 2002
In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important moldsT Nakai, J Uno, K Otomo, et al.
The Journal of Antibiotics|December 1, 1988
In vivo antibacterial activity of FK482, a new orally active cephalosporinY Mine, Y Yokota, Y Wakai, et al.
The Journal of Antibiotics|October 8, 1999
In vitro antibacterial activity of FK041, a new orally active cephalosporinY Watanabe, K Hatano, Y Matsumoto, et al.
The Journal of Antibiotics|January 1, 1993
Animal pharmacokinetics of FK037, a novel parenteral broad-spectrum cephalosporinH Sakamoto, K Hatano, Y Higashi, et al.
Bioorganic & Medicinal Chemistry|March 16, 2001
Orally active cephalosporins. Part 3: synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporinsH Yamamoto, T Terasawa, A Nakamura, et al.
The Journal of Antibiotics|December 1, 1988
In vitro antibacterial activity of FK482, a new orally active cephalosporinY Mine, T Kamimura, Y Watanabe, et al.
Bioorganic & Medicinal Chemistry|September 1, 2000
Orally active cephalosporins: synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporinsH Yamamoto, T Terasawa, A Ohki, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosisF Ikeda, Y Wakai, S Matsumoto, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosisS Matsumoto, Y Wakai, T Nakai, et al.
Pageof 4